AAAAAA
Results:
1-16
|
Results: 16
Authors:
Hurley, MJ
Mash, DC
Jenner, P
Citation: Mj. Hurley et al., Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease, MOL BRAIN R, 87(2), 2001, pp. 271-279
Authors:
Baumann, MH
Rothman, RB
Pablo, JP
Mash, DC
Citation: Mh. Baumann et al., In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats, J PHARM EXP, 297(2), 2001, pp. 531-539
Authors:
Eshleman, AJ
Wolfrum, K
Mash, DC
Christensen, K
Janowsky, A
Citation: Aj. Eshleman et al., Drug interactions with the dopamine transporter in cryopreserved human caudate, J PHARM EXP, 296(2), 2001, pp. 442-449
Authors:
Mash, DC
Staley, JK
Izenwasser, S
Basile, M
Ruttenber, AJ
Citation: Dc. Mash et al., Serotonin transporters upregulate with chronic cocaine use, J CHEM NEUR, 20(3-4), 2000, pp. 271-280
Authors:
Hurley, MJ
Mash, DC
Jenner, P
Citation: Mj. Hurley et al., Adenosine A(2A) receptor mRNA expression in Parkinson's disease, NEUROSCI L, 291(1), 2000, pp. 54-58
Authors:
Wang, YH
TesFaye, E
Yasuda, RP
Mash, DC
Armstrong, DM
Wolfe, BB
Citation: Yh. Wang et al., Effects of post-mortem delay on subunits of ionotropic glutamate receptorsin human brain, MOL BRAIN R, 80(2), 2000, pp. 123-131
Authors:
Mufson, EJ
Deecher, DC
Basile, M
Izenwasse, S
Mash, DC
Citation: Ej. Mufson et al., Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis, NEUROPHARM, 39(8), 2000, pp. 1404-1412
Authors:
Mash, DC
Kramer, LC
Segal, D
Izenwasser, S
Citation: Dc. Mash et al., Dopamine transporter mRNA in human brain - Distribution and regulatory effects in autopsy studies of cocaine abusers, CONT NEUROS, 2000, pp. 401-417
Authors:
Zubaran, C
Shoaib, M
Stolerman, IP
Pablo, J
Mash, DC
Citation: C. Zubaran et al., Noribogaine generalization to the ibogaine stimulus: Correlation with noribogaine concentration in rat brain, NEUROPSYCH, 21(1), 1999, pp. 119-126
Authors:
Callaway, JC
McKenna, DJ
Grob, CS
Brito, GS
Raymon, LP
Poland, RE
Andrade, EN
Andrade, EO
Mash, DC
Citation: Jc. Callaway et al., Pharmacokinetics of Hoasca alkaloids in healthy humans, J ETHNOPHAR, 65(3), 1999, pp. 243-256
Authors:
Chen, L
Segal, DM
Moraes, CT
Mash, DC
Citation: L. Chen et al., Dopamine transporter mRNA in autopsy studies of chronic cocaine users, MOL BRAIN R, 73(1-2), 1999, pp. 181-185
Authors:
Izenwasser, S
Staley, JK
Cohn, S
Mash, DC
Citation: S. Izenwasser et al., Characterization of kappa(1)-opioid receptor binding in human insular cortex, LIFE SCI, 65(9), 1999, pp. 857-862
Authors:
Ma, SY
Ciliax, BJ
Stebbins, G
Jaffar, S
Joyce, JN
Cochran, EJ
Kordower, JH
Mash, DC
Levey, AI
Mufson, EJ
Citation: Sy. Ma et al., Dopamine transporter-immunoreactive neurons decrease with age in the humansubstantia nigra, J COMP NEUR, 409(1), 1999, pp. 25-37
Authors:
Ciliax, BJ
Drash, GW
Staley, JK
Haber, S
Mobley, CJ
Miller, GW
Mufson, EJ
Mash, DC
Levey, AI
Citation: Bj. Ciliax et al., Immunocytochemical localization of the dopamine transporter in human brain, J COMP NEUR, 409(1), 1999, pp. 38-56
Authors:
Miller, GW
Erickson, JD
Perez, JT
Penland, SN
Mash, DC
Rye, DB
Levey, AI
Citation: Gw. Miller et al., Immunochemical analysis of vesicular monoamine transporter (VMAT2) proteinin Parkinson's disease, EXP NEUROL, 156(1), 1999, pp. 138-148
Authors:
Hulette, CM
Welsh-Bohmer, KA
Murray, MG
Saunders, AM
Mash, DC
McIntyre, LM
Citation: Cm. Hulette et al., Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals, J NE EXP NE, 57(12), 1998, pp. 1168-1174
Risultati:
1-16
|